Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Synergistic potential of CDH3 in targeting CRC metastasis and enhancing immunotherapy

Fig. 4

Experimental verification of CDH3 (A) protein expression in normal, colon cancer, and metastatic colon cancer tissues from clinical samples. (B) Immunohistochemical results and statistics of normal, colon cancer, and metastatic colon cancer tissues. (C) Comparison of survival curves between clinical colorectal cancer patients and normal patients. (D) Comparison of survival curves between clinical colorectal cancer patients and metastatic colorectal cancer patients

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us